Novartis and GlaxoSmithKline have agreed a multibillion dollar swap of assets under which the two pharmaceutical companies will join forces in the consumer healthcare sector combining brands including Aquafresh, Beechams and Tixylix and exchange their oncology and vaccine businesses.
Showing posts with label oncology business. Show all posts
Showing posts with label oncology business. Show all posts
Subscribe to:
Posts (Atom)